|
1.
|
Livraghi T, Mäkisalo H and Line PD:
Treatment options in hepatocellular carcinoma today. Scand J Surg.
100:22–29. 2011.PubMed/NCBI
|
|
2.
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Zhou WP, Lai EC, Li AJ, Fu SY, Zhou JP,
Pan ZY, Lau WY and Wu MC: A prospective, randomized, controlled
trial of preoperative transarterial chemoembolization for
resectable large hepatocellular carcinoma. Ann Surg. 249:195–202.
2009. View Article : Google Scholar
|
|
4.
|
Nishikawa H, Osaki Y, Kita R, Kimura T,
Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A, Henmi S,
Hatamaru K, Saito S and Nasu A: Transcatheter arterial infusion
chemotherapy prior to radiofrequency thermal ablation for single
hepatocellular carcinoma reduces the risk of intrahepatic distant
recurrence. Int J Oncol. 41:903–909. 2012.
|
|
5.
|
de Lope CR, Tremosini S, Forner A, Reig M
and Bruix J: Management of HCC. J Hepatol. 56(Suppl 1): S75–S87.
2012.
|
|
6.
|
Takayasu K, Arii S, Ikai I, Omata M, Okita
K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M and Makuuchi M:
Prospective cohort study of transarterial chemoembolization for
unresectable hepatocellular carcinoma in 8510 patients.
Gastroenterology. 131:461–469. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Nishikawa H, Osaki Y, Inuzuka T, Takeda H,
Nakajima J, Matsuda F, Henmi S, Sakamoto A, Ishikawa T, Saito S,
Kita R and Kimura T: Branched-chain amino acid treatment before
transcatheter arterial chemoembolization for hepatocellular
carcinoma. World J Gastroenterol. 18:1379–1384. 2012. View Article : Google Scholar
|
|
8.
|
Llovet JM and Bruix J: Systematic review
of randomized trials for unresectable hepatocellular carcinoma:
chemoembolization improves survival. Hepatology. 37:429–442. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Bruix J and Sherman M; Practice Guidelines
Committee, American Association for the Study of Liver Diseases:
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar
|
|
10.
|
Kaibori M, Tanigawa N, Kariya S, Ikeda H,
Nakahashi Y, Hirohara J, Koreeda C, Seki T, Sawada S, Okazaki K and
Kwon AH: A prospective randomized controlled trial of preoperative
whole-liver chemolipiodolization for hepatocellular carcinoma. Dig
Dis Sci. 57:1404–1412. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Yamanaka N, Okamoto E, Fujihara S, Kato T,
Fujimoto J, Oriyama T, Mitsunobu M, Toyosaka A, Uematsu K and
Yamamoto K: Do the tumor cells of hepatocellular carcinomas
dislodge into the portal venous stream during hepatic resection?
Cancer. 70:2263–2267. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Yamasaki S, Hasegawa H, Kinoshita H,
Furukawa M, Imaoka S, Takasaki K, Kakumoto Y, Saitsu H, Yamada R,
Oosaki Y, Arii S, Okamoto E, Monden M, Ryu M, Kusano S, Kanematsu
T, Ikeda K, Yamamoto M, Saoshiro T and Tsuzuki T: A prospective
randomized trial of the preventive effect of pre-operative
transcatheter arterial embolization against recurrence of
hepatocellular carcinoma. Jpn J Cancer Res. 87:206–211. 1996.
View Article : Google Scholar
|
|
13.
|
Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ and
P’eng FK: Preoperative transcatheter arterial chemoembolization for
resectable large hepatocellular carcinoma: a reappraisal. Br J
Surg. 82:122–126. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Yamasaki T, Kurokawa F, Shirahashi H,
Kusano N, Hironaka K and Okita K: Percutaneous radiofrequency
ablation therapy with combined angiography and computed tomography
assistance for patients with hepatocellular carcinoma. Cancer.
91:1342–1348. 2001. View Article : Google Scholar
|
|
15.
|
Liver Cancer Study Group of Japan: The
general rules for the clinical and pathological study of primary
liver cancer. Jpn J Surg. 19:98–129. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Kudo M and Okanoue T: Management of
hepatocellular carcinoma in Japan: consensus-based clinical
practice manual proposed by the Japan Society of Hepatology.
Oncology. 72(Suppl 1): 2–15. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Kudo M, Kubo S, Takayasu K, Sakamoto M,
Tanaka M, Ikai I, Furuse J, Nakamura K and Makuuchi M; Liver Cancer
Study Group of Japan (Committee for Response Evaluation Criteria in
Cancer of the Liver, Liver Cancer Study Group of Japan): Response
Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the
Liver Cancer Study Group of Japan (2009 Revised Version). Hepatol
Res. 40:686–692. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Hu BS, Chen K, Tan HM, Ding XM and Tan JW:
Comparison of laparoscopic vs open liver lobectomy (segmentectomy)
for hepatocellular carcinoma. World J Gastroenterol. 17:4725–4728.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Sasaki A, Iwashita Y, Shibata K, Ohta M,
Kitano S and Mori M: Preoperative transcatheter arterial
chemoembolization reduces long-term survival rate after hepatic
resection for resectable hepatocellular carcinoma. Eur J Surg
Oncol. 32:773–779. 2006. View Article : Google Scholar
|
|
20.
|
Choi GH, Kim DH, Kang CM, Kim KS, Choi JS,
Lee WJ and Kim BR: Is preoperative transarterial chemoembolization
needed for a resectable hepatocellular carcinoma? World J Surg.
31:2370–2377. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Sugo H, Futagawa S, Beppu T, Fukasawa M
and Kojima K: Role of preoperative transcatheter arterial
chemoembolization for resectable hepatocellular carcinoma: relation
between postoperative course and the pattern of tumor recurrence.
World J Surg. 27:1295–1299. 2003. View Article : Google Scholar
|
|
22.
|
Sergio A, Cristofori C, Cardin R, Pivetta
G, Ragazzi R, Baldan A, Girardi L, Cillo U, Burra P, Giacomin A and
Farinati F: Transcatheter arterial chemoembolization (TACE) in
hepatocellular carcinoma (HCC): the role of angiogenesis and
invasiveness. Am J Gastroenterol. 103:914–921. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Zhang Z, Liu Q, He J, Yang J, Yang G and
Wu M: The effect of preoperative transcatheter hepatic arterial
chemoembolization on disease-free survival after hepatectomy for
hepatocellular carcinoma. Cancer. 89:2606–2612. 2000. View Article : Google Scholar
|
|
24.
|
Adachi E, Matsumata T, Nishizaki T,
Hashimoto H, Tsuneyoshi M and Sugimachi K: Effects of preoperative
transcatheter hepatic arterial chemoembolization for hepatocellular
carcinoma. The relationship between postoperative course and tumor
necrosis. Cancer. 72:3593–3598. 1998. View Article : Google Scholar
|
|
25.
|
Chao Y, Li CP, Chau GY, Chen CP, King KL,
Lui WY, Yen SH, Chang FY, Chan WK and Lee SD: Prognostic
significance of vascular endothelial growth factor, basic
fibroblast growth factor, and angiogenin in patients with
resectable hepatocellular carcinoma after surgery. Ann Surg Oncol.
10:355–362. 2003. View Article : Google Scholar
|
|
26.
|
Poon RT, Lau C, Yu WC, Fan ST and Wong J:
High serum levels of vascular endothelial growth factor predict
poor response to transarterial chemoembolization in hepatocellular
carcinoma: a prospective study. Oncol Rep. 11:1077–1084. 2004.
|
|
27.
|
Shim JH, Park JW, Kim JH, An M, Kong SY,
Nam BH, Choi JI, Kim HB, Lee WJ and Kim CM: Association between
increment of serum VEGF level and prognosis after transcatheter
arterial chemoembolization in hepatocellular carcinoma patients.
Cancer Sci. 99:2037–2044. 2008.
|
|
28.
|
Ikai I, Arii S, Kojiro M, Ichida T,
Makuuchi M, Matsuyama Y, Nakanuma Y, Okita K, Omata M, Takayasu K
and Yamaoka Y: Reevaluation of prognostic factors for survival
after liver resection in patients with hepatocellular carcinoma in
a Japanese nationwide survey. Cancer. 101:796–802. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Gluer AM, Cocco N, Laurence JM, Johnston
ES, Hollands MJ, Pleass HC, Richardson AJ and Lam VW: Systematic
review of actual 10-year survival following resection for
hepatocellular carcinoma. HPB. 14:285–290. 2012.PubMed/NCBI
|
|
30.
|
Zhou L, Liu J and Luo F: Serum tumor
markers for detection of hepatocellular carcinoma. World J
Gastroenterol. 12:1175–1181. 2006.PubMed/NCBI
|
|
31.
|
Lim KC, Chow PK, Allen JC, Chia GS, Lim M,
Cheow PC, Chung AY, Ooi LL and Tan SB: Microvascular invasion is a
better predictor of tumor recurrence and overall survival following
surgical resection for hepatocellular carcinoma compared to the
Milan criteria. Ann Surg. 254:108–113. 2011. View Article : Google Scholar
|
